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t(2;12)(q31;p13) G- banding – Coutesy Melanie Zenger and 
Claudia Haferlach. 
Clinics and pathology 
Disease 
Non Hodgkin lymphoma (NHL) and myelodysplastic 
syndrome (chronic myelomonocytic leukemia (CMML) 
Epidemiology 
Only 2 cases to date (male patients): 1 NHL aged 30 
years and 1 CMML aged 78 years 
Prognosis 
The CMML case died 2 years 9 months after diagnosis 
Cytogenetics 
Additional anomalies 
del(11q) in the NHL case and +21 in the CMML case. 
Genes involved and Proteins 
Note: ETV6 was found involved in the NHL case. 
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